Supplementary Material for Đorđević M, Stepper P, Feuerstein-Akgoz C, Gerhauser C, Paunović V, Tolić A, Rajić J, Dinić S, Uskoković A, Grdović N, Mihailović M, Jurkowska RZ, Jurkowski TP, Jovanović JA, Vidaković M. EpiCRISPR targeted methylation of Arx gene initiates transient switch of mouse pancreatic alpha to insulin-producing cells. Front Endocrinol (Lausanne). 2023;14:1134478.
2023
Аутори:
Đorđević, MarijaStepper, Peter
Feuerstein-Akgoz, Clarissa
Gerhauser, Clarissa
Paunović, Verica
Tolić, Anja
Rajić, Jovana
Dinić, Svetlana
Uskoković, Aleksandra
Grdović, Nevena
Mihailović, Mirjana
Jurkowska, Renata
Jurkowski, Tomasz
Arambašić Jovanović, Jelena
Vidaković, Melita
Тип документа:
Скуп података (Објављена верзија)
,
© 2023 Đorđević, Stepper, Feuerstein-Akgoz, Gerhauser, Paunović, Tolić, Rajić, Dinić, Uskoković, Grdović, Mihailović, Jurkowska, Jurkowski, Jovanović and Vidaković
Метаподаци
Приказ свих података о документуАпстракт:
Figure 1. UCSC genome browser views of murine Arx gene’s DNA methylation sites in the pancreas and other tissues. If compared with other tissues, Arx gene in pancreatic tissue (young and old) exhibits low DNA methylation. CpG island was shown as a green box. Table 1. Targeted sequences for sgRNAs. Table 2. Primers used for RT-qPCR. Table 3. Primers used for HRM. Table 4. Touchdown PCR program for amplification of bisulfite converted DNA, starting at 55 °C. Table 5. Primers for NGS library preparation. Table 6. Antibodies used for Immunoblot analysis (IBA) and Immunocytochemistry (ICC). Table 7. Primers for PCR reaction after ChIP.
Кључне речи:
Arx gene; CRISPR/dCas9; diabetes; pancreatic alpha cells; epigenetic editing; targeted DNA methylationИзвор:
Frontiers in Endocrinology, Section - Diabetes: Molecular Mechanisms, 2023, 14, 1134478-Финансирање / пројекти:
- European Cooperation in Science and Technology (COST)
- European Foundation for the Study of Diabetes (EFSD), European Diabetes Research Programme in Cellular Plasticity Underlying the Pathophysiology of Type 2 Diabetes, research grant from Astra Zeneca
- Министарство науке, технолошког развоја и иновација Републике Србије, институционално финансирање - 200007 (Универзитет у Београду, Институт за биолошка истраживања 'Синиша Станковић') (RS-MESTD-inst-2020-200007)
Повезане информације:
- Повезани садржај
https://radar.ibiss.bg.ac.rs/handle/123456789/5507